Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9677
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDonnan, Geoffrey Aen
dc.date.accessioned2015-05-15T22:51:36Z
dc.date.available2015-05-15T22:51:36Z
dc.date.issued2004-01-01en
dc.identifier.citationThe Lancet. Neurology; 3(1): 9en
dc.identifier.govdoc14693098en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/9677en
dc.language.isoenen
dc.subject.other3',5'-Cyclic-AMP Phosphodiesterases.geneticsen
dc.subject.otherAntihypertensive Agents.therapeutic useen
dc.subject.otherBlood Pressure.drug effectsen
dc.subject.otherClinical Trials as Topicen
dc.subject.otherCyclic Nucleotide Phosphodiesterases, Type 4en
dc.subject.otherFibrinolytic Agents.adverse effects.therapeutic useen
dc.subject.otherHumansen
dc.subject.otherRisk Factorsen
dc.subject.otherStroke.genetics.mortality.prevention & controlen
dc.subject.otherTreatment Outcomeen
dc.titleStroke: prediction, prevention, and outcome.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Lancet. Neurologyen
dc.identifier.affiliationNational Stroke Research Institute, Austin & Repatriation Medical Centre, University of Melbourne, Heidelberg West, Victoria, Australiaen
dc.description.pages9en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/14693098en
dc.type.austinJournal Articleen
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.